|
1
|
Zheng L, Qi T, Yang D, et al: microRNA-9
suppresses the proliferation, invasion and metastasis of gastric
cancer cells through targeting cyclin D1 and Ets1. PLoS One.
8:e557192013.
|
|
2
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
|
|
3
|
Nagase H, Visse R and Murphy G: Structure
and function of matrix metalloproteinases and TIMPs. Cardiovasc
Res. 69:562–573. 2006.
|
|
4
|
Murray G, Duncan M, Arbuckle E, Melvin W
and Fothergill J: Matrix metalloproteinases and their inhibitors in
gastric cancer. Gut. 43:791–797. 1998.
|
|
5
|
Partyka R, Gonciarz M, Jalowiecki P,
Kokocinska D and Byrczek T: VEGF and metalloproteinase 2 (MMP 2)
expression in gastric cancer tissue. Med Sci Monit. 18:BR130–BR134.
2012.
|
|
6
|
Zhou J, Zhu P, Jiang JL, et al:
Involvement of CD147 in overexpression of MMP-2 and MMP-9 and
enhancement of invasive potential of PMA-differentiated THP-1. BMC
Cell Biol. 6:252005.
|
|
7
|
Tang W, Chang SB and Hemler ME: Links
between CD147 function, glycosylation, and caveolin-1. Mol Biol
Cell. 15:4043–4050. 2004.
|
|
8
|
Jiang JL, Chan HC, Zhou Q, et al:
HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis
require both C-terminal and N-terminal domains. Cell Mol Life Sci.
61:2083–2091. 2004.
|
|
9
|
Voigt H, Vetter-Kauczok CS, Schrama D,
Hofmann UB, Becker JC and Houben R: CD147 impacts angiogenesis and
metastasis formation. Cancer Invest. 27:329–333. 2009.
|
|
10
|
Zheng HC, Takahashi H, Murai Y, et al:
Upregulated EMMPRIN/CD147 might contribute to growth and
angiogenesis of gastric carcinoma: a good marker for local invasion
and prognosis. Br J Cancer. 95:1371–1378. 2006.
|
|
11
|
Wang B, Xu YF, He BS, et al: RNAi-mediated
silencing of CD147 inhibits tumor cell proliferation, invasion and
increases chemosensitivity to cisplatin in SGC7901 cells in vitro.
J Exp Clin Cancer Res. 29:612010.
|
|
12
|
Li J, He J and Yu C: Chitosan
oligosaccharide inhibits LPS-induced apoptosis of vascular
endothelial cells through the BKCa channel and the p38 signaling
pathway. Int J Mol Med. 30:157–164. 2012.
|
|
13
|
Lee JK, Lim HS and Kim JH: Cytotoxic
activity of aminoderivatized cationic chitosan derivatives. Bioorg
Med Chem Lett. 12:2949–2951. 2002.
|
|
14
|
Chen D, Wang Y, Zhang K, Jiao X, Yan B and
Liang J: Antisense oligonucleotide against clusterin regulates
human hepatocellular carcinoma invasion through transcriptional
regulation of matrix metalloproteinase-2 and e-cadherin. Int J Mol
Sci. 13:10594–10607. 2012.
|
|
15
|
Nam KS and Shon YH: Suppression of
metastasis of human breast cancer cells by chitosan
oligosaccharides. J Microbiol Biotechnol. 19:629–633. 2009.
|
|
16
|
Shen KT, Chen MH, Chan HY, Jeng JH and
Wang YJ: Inhibitory effects of chitooligosaccharides on tumor
growth and metastasis. Food Chem Toxicol. 47:1864–1871. 2009.
|
|
17
|
Karagozlu MZ, Kim JA, Karadeniz F, Kong CS
and Kim SK: Anti-proliferative effect of aminoderivatized
chitooligosaccharides on AGS human gastric cancer cells. Process
Biochem. 45:1523–1528. 2010.
|
|
18
|
Rundhaug JE: Matrix metalloproteinases,
angiogenesis, and cancer: commentary re: A. C. Lockhart et al.,
Reduction of wound angiogenesis in patients treated with
BMS-275291, a broad spectrum matrix metalloproteinase inhibitor
Clin Cancer Res, 9: 00-00, 2003. Clin Cancer Res. 9:551–554.
2003.
|
|
19
|
Kim MM and Kim SK: Chitooligosaccharides
inhibit activation and expression of matrix metalloproteinase-2 in
human dermal fibroblasts. FEBS Lett. 580:2661–2666. 2006.
|
|
20
|
Van Ta Q, Kim MM and Kim SK: Inhibitory
effect of chitooligosaccharides on matrix metalloproteinase-9 in
human fibrosarcoma cells (HT1080). Mar Biotechnol (NY). 8:593–599.
2006.
|
|
21
|
Rajapakse N, Kim MM, Mendis E, Huang R and
Kim SK: Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9
expression in human fibrosarcoma cells via down-regulation of AP-1.
Biochim Biophys Acta. 1760:1780–1788. 2006.
|
|
22
|
Omi Y, Shibata N, Okamoto T, Obara T and
Kobayashi M: The role of CD147 in the invasiveness of follicular
thyroid carcinoma cells. Thyroid. 22:383–394. 2012.
|
|
23
|
Huang W, Luo WJ, Zhu P, et al: Modulation
of CD147-induced matrix metalloproteinase activity: role of CD147
N-glycosylation. Biochem J. 449:437–448. 2013.
|
|
24
|
Li R, Pan Y, He B, et al: Downregulation
of CD147 expression by RNA interference inhibits HT29 cell
proliferation, invasion and tumorigenicity in vitro and in vivo.
Int J Oncol. 43:1885–1894. 2013.
|
|
25
|
Chen L, Pan Y, Gu L, et al: ERK1/2
signalling pathway is involved in CD147-mediated gastric cancer
cell line SGC7901 proliferation and invasion. Exp Biol Med
(Maywood). 238:903–912. 2013.
|
